How were NightHawk Biosciences' earnings last quarter?

NightHawk Biosciences, Inc. (NYSE:NHWK) posted its quarterly earnings data on Tuesday, November, 9th. The biopharmaceutical company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.29) by $0.01. The biopharmaceutical company had revenue of $0.50 million for the quarter, compared to analyst estimates of $0.57 million. NightHawk Biosciences had a negative trailing twelve-month return on equity of 91.62% and a negative net margin of 2,333.27%.

When did NightHawk Biosciences' stock split?

Shares of NightHawk Biosciences reverse split on the morning of Friday, December 11th 2020. The 1-7 reverse split was announced on Thursday, December 10th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Friday, December 11th 2020. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

NYSE:NHWK

NightHawk Biosciences (NHWK) Stock Price, News & Analysis

→ New York goes dark, then America. (From Porter & Company) (Ad)

Free NHWK Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: N/A
50-Day Range: $0.26
▼
$0.50
52-Week Range: N/A

Volume: 173,100 shs
Average Volume: 97,242 shs
Market Capitalization: $10.78 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Earnings Headlines Insider Trades Ownership Social Media

Get NightHawk Biosciences alerts:

Ad Timothy Sykes

Urgent alert: open this for a huge profit potential

This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.

See Tim’s instructions to make this remarkably simple trade right here

About NightHawk Biosciences Stock (NYSE:NHWK)

NightHawk Biosciences, Inc., an integrated biopharmaceutical company, develops, manufactures, and commercializes medical countermeasures that combat unmet and emerging biothreats. The company develops ANTHIM (obiltoxaximab), a monoclonal antibody antitoxin for the treatment of inhalational anthrax. The company was formerly known as Heat Biologics, Inc. and changed its name to NightHawk Biosciences, Inc. in May 2022. NightHawk Biosciences, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.

Ad Timothy Sykes

Urgent alert: open this for a huge profit potential

This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.

See Tim’s instructions to make this remarkably simple trade right here

NHWK Stock News Headlines

March 19, 2024 | globenewswire.com

Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major University

March 14, 2024 | globenewswire.com

Scorpius Holdings Accepted as a Member of the US Government's BioMaP-Consortium

April 20, 2024 | Porter & Company (Ad)

New York goes dark, then America.

Artificial intelligence is about to trigger a shocking new crisis in New York. Experts warn it could be “the next 9/11” and while New York will be ground zero for this looming catastrophe, it will not be the only state impacted. This crisis could affect 233 million Americans starting at any moment from now.

March 12, 2024 | globenewswire.com

Scorpius Holdings, Inc. Announces Closing of Public Offering

March 8, 2024 | globenewswire.com

Scorpius Holdings, Inc. Announces Pricing of Public Offering

March 7, 2024 | globenewswire.com

Scorpius Holdings, Inc. Announces Proposed Public Offering of Common Stock

March 7, 2024 | globenewswire.com

Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023

March 7, 2024 | globenewswire.com

Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023

April 20, 2024 | Porter & Company (Ad)

New York goes dark, then America.

February 13, 2024 | uk.finance.yahoo.com

Scorpius Holdings, Inc. (SCPX)

February 7, 2024 | msn.com

NightHawk Biosciences Debuts SCPX Ticker on NYSE American

February 7, 2024 | msn.com

NightHawk Biosciences Unveils New Name and Ticker

January 31, 2024 | msn.com

NightHawk Biosciences Strikes Key Licensing and Financing Deals

January 30, 2024 | finance.yahoo.com

NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing Note

January 25, 2024 | finance.yahoo.com

NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical Program

January 17, 2024 | finanznachrichten.de

NightHawk Biosciences: NightHawk's Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New Client

January 16, 2024 | finance.yahoo.com

NightHawk’s Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New Client

January 11, 2024 | msn.com

NHWK: Transformational Changes

January 8, 2024 | msn.com

NightHawk Biosciences changing name to Scorpius, ticker to SCPX

January 8, 2024 | finance.yahoo.com

NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMO

January 3, 2024 | finance.yahoo.com

NightHawk Biosciences Commences Work on Multi-Million-Dollar Development and Manufacturing Agreement For a Leading National University

December 21, 2023 | finance.yahoo.com

NightHawk Biosciences Announces Completion of Demonstration Run for a Top-Tier NIH and DTRA Funded Research University

December 19, 2023 | msn.com

NightHawk Biosciences files for $200M mixed securities shelf

December 18, 2023 | finance.yahoo.com

NightHawk Biosciences Announces Major Milestone with Completion of Manufacturing Run for a Premier U.S.-Based Biopharmaceutical Company

December 12, 2023 | finance.yahoo.com

NightHawk Biosciences Announces Strategic Shift into a Pure-Play Large Molecule Biomanufacturing CDMO to Capitalize on Rapid Growth in Sales Pipeline along with Divestiture of Non-Core Assets

December 3, 2023 | morningstar.com

NightHawk Biosciences Inc NHWK

November 29, 2023 | bizjournals.com

Morrisville public company looks to divest subsidiary after CEO tried to buy it

See More Headlines

Receive NHWK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NightHawk Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/09/2021
Today: 4/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NYSE:NHWK
CUSIP: N/A
CIK: 1476963
Web: www.nighthawkbio.com
Phone: 919-240-7133
Fax: N/A
Employees: 77
Year Founded: 2008

Profitability

EPS (Most Recent Fiscal Year): ($1.99)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-43,440,000.00
Net Margins: -2,333.27%
Pretax Margin: -2,546.97%
Return on Equity: -91.62%
Return on Assets: -56.48%

Debt

Debt-to-Equity Ratio: 0.27
Current Ratio: 0.99
Quick Ratio: 0.99

Sales & Book Value

Annual Sales: $6.38 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.82 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 26,080,000
Free Float: 21,935,000
Market Cap: $10.78 million
Optionable: Optionable
Beta: 0.19

Social Links

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Jeffrey Alan Wolf J.D. (Age 61)
Founder, Chairman of the Board, CEO & President
Comp: $842.6k
Mr. William L. Ostrander (Age 56)
CFO & Secretary
Comp: $476.24k
Dr. Justin Stebbing FRCP
FRCPath, M.A., M.D., Ph.D., Chief Medical Advisor and Member of Scientific & Clinical Advisory Board
Colonel George E. Peoples Jr.
F.A.C.S., M.D., Chief Medical Advisor
Ms. Ania Szymanska
Head of Quality

Key Competitors

View All Competitors

Institutional Ownership

Simplex Trading LLC
Sold 1,000 shares on 2/2/2024
Ownership: 0.000%

View All Institutional Transactions

NHWK Stock Analysis - Frequently Asked Questions

How were NightHawk Biosciences' earnings last quarter?: NightHawk Biosciences, Inc. (NYSE:NHWK) posted its quarterly earnings data on Tuesday, November, 9th. The biopharmaceutical company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.29) by $0.01. The biopharmaceutical company had revenue of $0.50 million for the quarter, compared to analyst estimates of $0.57 million. NightHawk Biosciences had a negative trailing twelve-month return on equity of 91.62% and a negative net margin of 2,333.27%.
When did NightHawk Biosciences' stock split?: Shares of NightHawk Biosciences reverse split on the morning of Friday, December 11th 2020. The 1-7 reverse split was announced on Thursday, December 10th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Friday, December 11th 2020. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

This page (NYSE:NHWK) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

NightHawk Biosciences (NHWK) Stock Price, News & Analysis

About NightHawk Biosciences Stock (NYSE:NHWK)

NHWK Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Institutional Ownership

NHWK Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info